Notably, a growing body of evidence supports a protective role for breastfeeding against breast cancer, especially the aggressive triple-negative subtype (TNBC), which lacks expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). The gene discussed is ESR1; the disease is breast carcinoma.